| ( 1 of 5 ) |
| United States Patent | 5,071,873 |
| Kakimoto , et al. | December 10, 1991 |
Antioxidant
Abstract
A new synthetic antioxidant comprising an organogermanium compound represented by the formula: ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 are one of a hydrogen atom, a substituted or unsubstituted phenyl group or an alkyl group, Y is a hydroxyl or amino group and Z is an oxygen or sulfur atom, is particularly effective in inhibiting auto-oxidation in living organisms.
| Inventors: | Kakimoto; Norihiro (Tokyo, JP); Namiki; Mitsuo (Aichi, JP); Osawa; Toshihiko (Aichi, JP); Miyao; Kohei (Tokyo, JP) |
| Assignee: | Asai Germanium Research Institute (Tokyo, JP) |
| Appl. No.: | 348129 |
| Filed: | May 3, 1989 |
Foreign Application Priority Data
| Apr 25, 1984[JP] | 59-81921 |
| Current U.S. Class: | 514/492 |
| Intern'l Class: | A61K 031/28 |
| Field of Search: | 514/492 |
References Cited [Referenced By]
U.S. Patent Documents
| 3079414 | Feb., 1963 | Tamborski et al. | 514/492. |
| 3812167 | May., 1974 | Pahk | 514/492. |
| 4066678 | Jan., 1978 | Sato et al. | 514/492. |
| 4271084 | Jun., 1981 | Ishikawa et al. | 514/492. |
| 4279892 | Jul., 1981 | Ishida et al. | 514/492. |
| 4281015 | Jul., 1981 | Ishikawa et al. | 514/492. |
| 4296123 | Oct., 1981 | Ishikawa et al. | 514/492. |
| 4309412 | Jan., 1982 | Ishikawa et al. | 514/492. |
| 4321273 | Mar., 1982 | Ishikawa et al. | 514/492. |
| 4322402 | Mar., 1982 | Ishikawa et al. | 514/492. |
| 4420430 | Dec., 1983 | Chang et al. | 514/492. |
| 4473581 | Sep., 1984 | Ishida et al. | 514/492. |
| 4508654 | Apr., 1985 | Chang et al. | 514/492. |
| 4681960 | Jul., 1987 | Kakimoto et al. | 514/492. |
| Foreign Patent Documents | |||
| 0016444 | Oct., 1980 | EP | 514/492. |
| 0086569 | Aug., 1983 | EP | 514/492. |
| 54-147932 | Nov., 1979 | JP | 514/492. |
| 56-120689 | Sep., 1981 | JP | 514/492. |
| 57-203090 | Dec., 1982 | JP | 514/492. |
| 1257225 | Dec., 1971 | GB. | |
| 2143128 | Feb., 1985 | GB | 514/492. |
Primary Examiner: Friedman; Stanley J.
Attorney, Agent or Firm: Burns, Doane, Swecker & Mathis
Parent Case Text
This application is a continuation of application Ser. No. 932,083, filed Nov.
18, 1986, now abandoned, which is a divisional of application Ser. No. 726,248,
filed Apr. 23, 1985 now U.S. Pat. No. 4,720,564.
Claims
What is claimed is:
1. A method of inhibiting the oxidation of a compound which is subject to
oxidation in a mammalian organism comprising administering to a mammalian
organism in need of such treatment an effective antioxidant amount of an
organogermanium compound represented by the general formula: ##STR17## wherein
R.sub.1, R.sub.2 and R.sub.3 are independently selected from a hydrogen atom, an
alkyl group, an unsubstituted phenyl group or a substituted phenyl group; Y is a
hydroxyl or amino group and Z is a sulfur atom.
2. The method according to claim 1 wherein R.sub.1, R.sub.2 and R.sub.3 are all
hydrogen atoms, Y is a hydroxy group and Z is a sulfur atom.
3. The method according to claim 1 wherein Y is a hydroxy group.
4. The method according to claim 1 wherein Y is an amino group.
5. The method according to claim 2 wherein Z is a sulfur atom.
Description
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a new type of antioxidant containing an
organogermanium compound as a principal ingredient.
2. Description of the Prior Art
Oxygen is an indispensable substance not only for human beings but also for all
aerobic organisms, but it is well known that oxygen causes various undesired
phenomena. For example, fat or oil contained in food is auto-oxidized with
oxygen in air to result not only in a decrease in the quality as a favorite food
and the nutritive value, but also in the generation of toxic substances by the
formation of peroxides. Further, in living organisms, the formation of peroxides
is recently noted as a cause of aging, cancerogenesis or the like.
That is to say, it is believed that an unsaturated fatty acid, for example,
polyunsaturated fatty acid which is particularly important as phospholipids or
the like and is an indispensable component in food as an essential fatty acid,
is subjected to auto-oxidation with free radical of oxygen or oxidant, which is
a free radical chain reaction, to form peroxylipids called "hydroperoxide", and
this hydroperoxide and products formed by the oxidative destruction of endo-peroxide
generated during the auto-oxidation, such as malonaldehyde, act on DNA, RNA,
protein or membrane tissue, thus taking part in the above diseases.
Adriamycin contained in anthracycline antineoplastic agent which is one of
chemotherapeutic agents used in the medical treatment of carcinoma is known to
have a particularly wide antineoplastic spectrum. However, it has been reported
that adriamycin exhibits some side effects. Furthermore, it has been proposed
that cardiotoxicity which is one of the side effects is caused by the
peroxidation of lipid with superoxide anion free radical (O.sub.2.sup.-),
hydroxyl free radical (OH), singlet oxygen ('O.sub.2) or the like which are
derived from the quinone structure present in the chemical structure of
adriamycin (Edward G. Mimnaugh et al., the Journal of Pharmacology and
Experimental Therapeutics, Vol. 226, No. 3,806 (1983)).
Many efforts have been made to inhibit the above auto-oxidation. Presently,
synthesized phenolic antioxidants such as butylhydroxyanisole (BHA) or
butylhydroxytoluene (BHT) and natural antioxidants such as tocopherol are known
and the former is widely used.
However, these synthetic antioxidants have disadvantages with respect to safety.
For example, BHA tends to cause disturbances in a liver. On the contrary,
natural antioxidant are known to have disadvantages with respect to the source
of supply, effects and cost. Therefore, some of the inventors of the present
invention had investigated in order to find effective natural antioxidant other
than tocopherol and succeeded in developing an effective, safe and natural
antioxidant containing n-tritriacontane-16, 18-dione which is contained in leaf
wax of eucalyptus, as a principal ingredient (Japanese Patent Publication No.
57-26744). Further, it is also desired that effective, safe and synthetic
antioxidants are developed.
SUMMARY OF THE INVENTION
The present invention has been made under these circumstances and is
characterized by containing an organogermanium compound represented by the
general formula: ##STR2## wherein R.sub.1, R.sub.2 and R.sub.3 are one of a
hydrogen atom, a substituted or unsubstituted phenyl group or an alkyl group, Y
is a hydroxyl or amino group and Z is an oxygen or sulfur atom.
BRIEF DESCRIPTION OF THE DRAWINGS
The attached drawings show the antioxidizing ability of the antioxidants
according to the present invention, wherein FIG. 1 shows the case where rabbit
red blood cell ghost is used, and
FIG. 2 shows the case where rat liver microsome is used, wherein (a) is the case
due to ADP-Fe.sup.+3, while (b) is the case due to adriamycin.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
The antioxidant of the present invention contains an organogermanium compound
represented by the general formula (I). In this formula, substituents R.sub.1,
R.sub.2 and R.sub.3 are one of a hydrogen atom, a substituted or unsubstituted
phenyl group or an alkyl group such as methyl or ethyl, and a substituent Y is a
hydroxyl or amino group.
A substituent Z stands for an oxygen or sulfur atom. Accordingly, when Z is 0,
the organogermanium compound represented by the general formula (I) is a
sesquioxide comprising the main structures and oxygen atoms which are bonded
with each other in a ratio of 2:3, while, when Z is S, it is a sesquisulfide
comprising the main structures and sulfur atoms which are bonded with each other
in a ratio of 2:3.
The organogermanium compounds to be used in the present invention are
expendiently represented by the general formula (I) according to a usual
practice. However, the organogermanium compound is a large molecule comprising
the main structures and oxygen or sulfur atoms which are bonded with each other
in a ratio of 2:3, and therefore the general formula (I) does not represent the
structure of this organogermanium compound exactly. Accordingly, the above
organogermanium compound can be also represented by the general formula:
##STR3## or by the general formula: ##STR4##
The above organogermanium compounds can be prepared by various methods.
For example, the sesquioxide compound represented by the general formula (I)
wherein Z is an oxygen atom, and Y is a hydroxyl group can be prepared by a
process which comprises reacting trichlorogermane
Cl.sub.3 GeH (II)
with an acrylic acid derivative ##STR5## to obtain a derivative of
trichlorogermylpropionic acid ##STR6## and hydrolyzing it, or by a process which
comprises reacting the above trichlorogermane (II) with an acrylonitrile
derivative ##STR7## to obtain a trichlorogermylpropionitrile derivative ##STR8##
and hydrolyzing it.
The sesquisulfide compound represented by the general formula (I) wherein Z is a
sulfur atom and Y is a hydroxyl group can be obtained by a process which
comprises dissolving the above trichlorogermylpropionic acid derivative (IV) in
an anhydrous solvent and passing dry hydrogen sulfide through the solution in
the presence of anhydrous pyridine.
In any case, the compound represented by the general formula (I) wherein Y is
NH.sub.2, can be obtained, for example, by a process which comprises reacting a
trichlorogermylpropionic acid derivative (IV) with a halogenating agent to form
the corresponding acyl halide and treating the halide with ammonia, followed
either by hydrolyzing the product or by passing dry hydrogen sulfide
therethrough.
In the preparation of the sesquioxide or sesquisulfide, it is believed that
ZH.sub.2 is eliminated intermolecularly from an intermediate (V) ##STR9## which
has first been formed to obtain the organogermanium compound represented by the
general formula (I).
The organogermanium compound synthesized as above was examined for antioxidizing
ability in living organism by mainly using a system similar to that in vitro.
More particularly, peroxidation due to t-butyl-hydroperoxide which is a kind of
peroxides was measured by using a system containing red blood cell ghost
(fragments of cell membrane) and peroxidation depending on NADPH due to
ADP-Fe.sup.3+, oxygen free radical, hydrogen peroxide and hydroxyl free radical
using P-450 system of rat liver microsome and peroxidation due to the above
adriamycin were measured. As a result of these measurements, it has been found
that the antioxidant of the present invention exhibits an excellent
antioxidizing ability like that of the above described tocopherol.
Now, experimental examples of the present invention will be described.
EXPERIMENTAL EXAMPLE 1
Synthesis of the Organogermanium Compound Represented by the General Formula (I)
1 Sesquioxide of 2-methyl-3-germylpropionic acid (1)
84.7 ml (0.1 mol) of methacrylic acid was added dropwise over 5 minutes to 18 g
(0.1 mol) of crude trichlorogermane which had been cooled to 5.degree. C. in an
ice bath. The mixture was stirred at the same temperature for one hour and then
at room temperature for 1.5 hour. The precipitated crystal was filtered by
suction, washed with 10 ml of n-hexane which had been dried over potassium
chloride for four times, dried by suction and kept in a desiccator containing
phosphorus pentoxide at 65.degree. C. for one hour with reducing the pressure by
a vacuum pump which uses potassium hydroxide containing trap to obtain 17.03 g
of crystalline 2-methyl-3-(trichlorogermyl) propionic acid:
melting point: 54.degree..about.55.degree. C.
IR spectrum (KBr, cm.sup.-1): 2950.about.3600, 1690, 1265, 580, 550, 405
NMR spectrum (CDCl.sub.3, .delta.): 1.46 (3H, d), 2.33 (2H, dd), 3.03 (1H, q),
10.13 (1H, s)
elemental analysis calculated: C 18.05, H 2.63, Cl 40.00. found: C 18.12, H
2.70, Cl 39.97.
10 ml of pure water was added to 2 g (0.0075 mol) of crystalline
2-methyl-3-(trichlorogermyl) propionic acid obtained according to the above
procedure. The temperature of the solution rose to 25.degree. C., and the
compound was completely dissolved. After 2 minutes, the solution became turbid
and crystal began to precipitate. The solution was heated to 85.degree. C. and
maintained at the temperature for one hour to precipitate the crystal
completely. The crystal was filtered, washed with 10 ml of pure water, 10 ml of
99.5% ethanol and then 10 ml of ether and dried by suction to obtain 0.638 g of
crystalline sesquioxide of 2-methyl-3-germylpropionic acid (yield: 86.3%).
##STR10##
IR spectrum (KBr, cm.sup.-1): 3420, 1705, 1245, 900, 802
NMR spectrum (D.sub.2 O, .delta.): 1.30 (3H, d), 1.68 (2H, dd), 2.93 (1H, m)
elemental analysis calculated: C 26.16, H 3.84. found: C 25.52, H 4.08.
2 Sesquioxide of 2-methyl-3-germylpropionamide (7)
100 ml of thionyl chloride was added to 26.6 g (0.1 mol) of
2-methyl-3-(trichlorogermyl) propionic acid prepared by the above process 1. The
mixture was heated under reflux for 10 hours and distilled under a reduced
pressure to remove excess thionyl chloride. 25.1 g of the corresponding acid
chloride was obtained as a colorless transparent portion having a boiling point
of 101 to 101.5.degree. C./6 mmHg (yield: 88%).
5.69 g (0.02 mol) of this chloride was dissolved in 150 ml of anhydrous benzene.
Dry ammonia was introduced into the solution under cooling with an ice bath for
one hour, followed by the introduction of gaseous hydrogen chloride for one
hour. 100 ml of methyl acetate was added to the solution and the mixture was
stirred and filtered. The filtrate was distilled and the obtained residue was
recrystallized from a mixture of acetone and benzene (1:2) to obtain 5 g of the
corresponding amide (yield: 79.8%).
5.70 g (0.02 mol) of the resulting amide was treated according to an ordinary
method to hydrolyze only the germanium-chlorine bonds. 3.01 g of the objective
compound having the following characteristics was obtained (yield: 79.8%).
##STR11##
IR spectrum (KBr, cm.sup.-1): 1660, 900, 800
elemental analysis calculated Ge: 39.73, C: 26.30, H: 4.41, N: 7.67. found Ge:
39.52, C: 26.37, H: 4.39, N: 7.61.
DTA:
endothermic peak at 246.degree. C.
exothermic peak at 315.degree. C.
Examples of the compounds represented by the general formula (I) wherein Z is 0
include the following compounds as well as the above compounds (1) and (7). The
following compounds can be prepared by the method similar to that described
above and exhibited the characteristics as shown in Table 1. ##STR12##
TABLE (1)
__________________________________________________________________________
Characteristics
Elemental analysis
Melting
IR
Com-
calculated/found point
(KBr, Yield
pound
Ge C H (.degree.C.)
cm.sup.-1)
(solvent)
NMR (.delta.)
(%)
__________________________________________________________________________
(2) 39.52/39.45
26.16/25.73
3.84/4.02
184.degree. C.
1700
D.sub.2 O
1.23 (3H, d)
98.0
(dec)
900 2.05 (1H, m)
800 2.67 (2H, dd)
(3) 36.72/36.60
30.37/30.39
4.59/4.58
228.degree. C.
1715
D.sub.2 O
1.20 (3H, d)
84.7
(dec)
880 1.30 (3H, d)
2.10 (1H, m)
2.90 (1H, m)
(4) 36.72/36.66
30.37/30.37
4.59/4.55
230.degree. C.
1690
D.sub.2 O
1.30 (6H, s)
65.8
(dec)
895 2.55 (2H, s)
795
(5) 29.54/29.55
43.99/44.01
3.69/3.61
200.degree. C.
1710
D.sub.2 O
3.00 (2H, s)
84.5
(dec)
880 3.35 (1H, t)
700 7.35 (5H, m)
(6) 27.94/27.99
46.23/46.21
4.27/4.27
200.degree. C.
1710
D.sub.2 O
1.15 (3H, m)
86.6
(dec)
880 3.20 (2H, d)
700 7.30 (5H, m)
__________________________________________________________________________
3 Sesquisulfide of 2-methyl-3-germylpropionic acid (15)
5.3 g (0.02 mol) of 2-methyl-3-(trichlorogermyl) propionic acid was dissolved in
100 ml of anhydrous benzene. 5.2 g (0.066 mol) of anhydrous pyridine was added
to the solution under cooling with an ice bath, followed by stirring. Dry
hydrogen sulfide was introduced into the mixture for one hour. The benzene was
removed and the residue was dissolved in 30 ml of methanol. The solution was
added to 100 ml of chilled water. The mixture was stirred for 2 hours to
precipitate crystal. The crystal was recrystallized from a mixture of methanol
and water (1:1) to obtain 3.9 g of crystalline sesquisulfide of
2-methyl-3-germyl propionic acid (yield: 93%). ##STR13##
IR spectrum (KBr, cm.sup.-1): 3450, 1705, 1245, 425
NMR spectrum (CD.sub.3 OD, .delta.): 1.38 (3H, d), 2.03 (2H, m), 2.94 (1H, m)
elemental analysis calculated: Ge 34.94, C 23.13, H 3.40, S 23.15. found: Ge
35.79, C 23.39, H 3.45, S 22.96.
4 Sesquisulfide of 3-phenyl-3-germylpropionic acid (18)
16.4 g (0.05 mol) of 3-phenyl-3-(trichlorogermyl) propionic acid was dissolved
in 200 ml of anhydrous acetone. 12.6 g (0.16 mol) of anhydrous pyridine was
added to the solution under cooling with an ice bath, followed by stirring. Dry
hydrogen sulfide was introduced into the mixture for one hour. The acetone was
removed and the residue was dissolved in 50 ml of ethanol. The solution was
added to 400 ml of water to precipitate the crystal. The crystal was
recrystallized from a mixture of methyl acetate and benzene (1:3) to obtain 12.7
g of crystalline sesquisulfide of 3-phenyl-3-germylpropionic acid. ##STR14##
IR spectrum (KBr, cm.sup.-1): 3450, 1710, 1600, 1410, 1230, 700, 425
NMR spectrum (acetone-d.sub.6, .delta.): 3.05 (2H, d), 3.62 (1H, t), 7.23 (5H,
m)
elemental analysis calculated: Ge 26.90, C 40.06, H 3.36, S 17.82. found: Ge
26.92, C 39.83, H 3.41, S 17.64.
5 Sesquisulfide of 2-methyl-3-germyl-3-methylpropionamide (23)
28.0 g (0.1 mol) of 2-methyl-3-(trichlorogermyl) butanoic acid was treated with
100 ml of thionyl chloride. The reaction mixture was distilled under a reduced
pressure to obtain 27.0 g of 2-methyl-3-(trichlorogermyl) butanoyl chloride as a
pale yellow portion having a boiling point of 99.degree. to 100.degree. C./6 mm
Hg (yield: 90.4%).
5.8 g (0.02 mol) of this chloride was dissolved in 50 ml of anhydrous benzene.
Dry ammonia was introduced into the solution under cooling with an ice bath for
one hour, followed by the introduction of gaseous hydrogen chloride for one
hour. 100 ml of methyl acetate was added and the mixture was stirred and
filtered. The filtrate was distilled and the residue was recrystallized from a
mixture of acetone and benzene (1:2) to obtain 4.1 g of
2-methyl-3-(trichlorogermyl) butanamide (yield: 76.0%).
10.8 g (0.04 mol) of the above 2-methyl-3-(trichlorogermyl) butanamide was
dissolved in 200 ml of anhydrous benzene. 9.5 g (0.12 mol) of anhydrous pyridine
was added to the solution, followed by stirring. Dry gaseous hydrogen sulfide
was passed through the solution for one hour. The precipitated compound was
separated and purified either by the recrystallization from hydrous acetone or
by the isolation using molecular sieves such as Sephadex LH-20 (trademark) and
methanol as a developer to obtain 7.8 g of the objective compound (yield:
88.3%). ##STR15##
melting point: 205.degree. C. (dec.)
IR (KBr, cm.sup.-1): 3400, 3200, 2960, 1660, 1460, 1400, 780, 570, 420
NMR (CD.sub.3 OD, .delta.): 1.30 (3H, d, CO--CH--CH), 1.38 (3H, d, Ge--CH--CH),
2.14 (1H, m, Ge--CH), 2.27 (1H, m, CO--CH), 2.70 (2H, d, NH.sub.2).
______________________________________
elemental analysis
Ge C H N S
______________________________________
calculated:
32.87 27.20 4.56 6.34 21.87
found: 32.59 27.37 4.43 6.25 21.56
______________________________________
Examples of the compounds represented by the general formula (I) wherein Z is S
include the following compounds as well as the above compounds (15), (18) and
(23). The following compounds were prepared by the methods similar to that
described above and exhibited the characteristics as shown in Table 2-1and-2.
##STR16##
TABLE 2-1
__________________________________________________________________________
Characteristics
Elemental analysis Melting
IR
Com-
calculated/found point
(KBr, Yield
pound
Ge C H S (.degree.C.)
cm.sup.-1)
(solvent)
NMR (.delta.)
(%)
__________________________________________________________________________
(14)
34.92/35.21
23.13/23.17
3.40/3.39
23.15/23.34
185.degree. C.
1705
CD.sub.3 OD
1.36 (3H, d)
57.7
(dec)
425 208.about.2.95 (3H, m)
(16)
32.73/32.53
27.07/27.26
4.09/4.10
21.68/21.57
200.degree. C.
1700
DC.sub.3 OD
1.33 (3H, d)
92.4
(dec)
400 1.40 (3H, d)
2.18 (1H, m)
2.60 (1H, m)
(17)
32.73/32.64
27.07/27.17
4.09/4.14
21.68/21.54
190.degree. C.
1700
CD.sub.3 OD
1.46 (6H, s)
80.3
(dec)
425 2.60 (2H, s)
(19)
25.57/25.49
42.31/42.33
3.91/3.90
16.94/16.99
190.degree. C.
1705
acetone
1.43 (3H, m)
86.0
(dec)
700 -d.sub.6
3.27 (2H, m)
425 7.17 (5H, s)
__________________________________________________________________________
TABLE 2-2
__________________________________________________________________________
Characteristics
Elemental analysis Melting
IR
Com- calculated/found point (KBr, Yield
pound
Ge C H N S (.degree.C.)
cm.sup.-1)
(Solvent)
NMR
(%)elta.)
__________________________________________________________________________
(14) 32.87/32.96
27.20/27.14
4.56/4.68
6.34/6.11
21.78/21.53
230.degree. C.
3400, 3200
CD.sub.3 OD
1.26 (6H,
76.5
(dec) 2960, 1660 2.86 (2H, s)
1460, 1120
420
(16) 27.00/27.26
40.20/40.34
3.75/3.93
5.21/5.18
17.89/17.66
210.degree. C.
3450, 3350
DMF d.sub.-6
2.43 (1H,
81.8
(dec) 3200, 1660 3.05 (2H, d)
1600, 1400 7.23 (5H, m)
765, 700, 420
(17) 25.66/25.87
42.46/42.49
4.27/4.33
4.95/4.70
17.00/16.86
215.degree. C.
3450, 3350 82.3
(dec) 3200, 1660
1455, 1400
700, 420
__________________________________________________________________________
[Example]
EXPERIMENTAL EXAMPLE 2
Test of the compound represented by the general formula (I) for antioxidizing
ability
Antioxidation test using an in-vitro system (rabbit red blood cell ghost)
About three times by volume as much isotonic liquid was added to 50.about.200 ml
of commercially available preserved rabbit blood. The mixture was subjected to
centrifugation three time at 3,500 r.p.m. for 20 minutes. About three times by
volume as much 10 mM phosphate buffer was added to the precipitate. The mixture
was subjected to centrifugation four times at 13,000 r.p.m. for 40 minutes. The
obtained precipitate was used as red blood cell ghost. The precipitate was
diluted so as to give a suspension containing about 10 mg of protein per 4 ml of
the buffer as determined by the Lowry's method. The corresponding amount of the
ghost suspension was placed in a test tube. 5 .mu.l of t-butyl hydroperoxide as
an oxidation accelerator and an antioxidant of the present invention diluted
with dimethyl sulfoxide (DMSO) or distilled water (when the antioxidant is
dissolved in DMSO, not more than 50 .mu.l of the solution is preferably used)
were added to the test tube, followed by the addition of the above 10 mM
phosphate buffer so as to give a total amount of 1 ml. The suspension was shaken
at 37.degree. C. for 20 minutes in a thermostatic chamber. 1 ml of a 20% aqueous
solution of TCA and 2 ml of a 0.67% aqueous solution of TBA were added to the
suspension. The mixture was heated in a boiling water bath for 15 minutes,
cooled with water and centrifuged at 3,500 r.p.m. for 15 minutes. The degree of
the antioxidizing effect was determined by measuring the absorbance of the
supernatant.
The ratio of the value obtained by subtracting the absorbance of the blank using
no t-butyl hydroperoxide from that of the control using t-butyl hydroperoxide to
the value of the absorbance of the control was calculated and shown by
percentage as antioxidation activity.
The results are shown in FIG. 1.
Antioxidation test using an in-vitro system (rat liver microsome)
1 The heads of Wistar rats (8 weeks, 180 to 200 g .male.) which had gone without
food for one day were cut off and their abdomens were cut to take out livers.
The livers were perfused with about 40 ml of a 0.95% chilled solution of sodium
chloride to remove blood contained in the livers. 80 ml (per liver of a rat) of
a 0.25M chilled colsution of sucrose was added to the livers and the mixture was
homogenized under cooling with an ice bath and centrifuged at 13,000 r.p.m. for
10 minutes. The supernatant was further centrifuged at 37,500 r.p.m. for one
hour. About 20 ml of a 125 mM solution of potassium chloride was added to the
precipitate and the resulting mixture was again homogenized to obtain a
microsome suspension.
The suspension was diluted so as to give a suspension containing 1.5 mg of
protein per 6.5 ml of buffer as measured by the Lowery's method.
The amount corresponding to a protein amount of 1.5 mg of the microsome
suspension was placed in a test tube. A proper amount of an antioxidant of the
present invention, ADP (400 .mu., final concentration--the same applies
hereinbelow), NADPH (120 .mu.M) and FeSO.sub.4.7H.sub.2 O (500 .mu.M) were added
to the test tube, followed by the addition of a mixture of 0.1M Trisbuffer (pH
7.4) and 0.15M KCl (1:2) so as to give a total amount of 1.5 ml. The mixture was
shaken in a thermostatic chamber at 37.degree. C. for 30 minutes. 3 ml of a 10%
solution of TCA and 2 ml of a 0.67% solution of TBA were added to the test tube.
The mixture was heated in a boiling water bath for 15 minutes, cooled with water
and centrifuged at 3,500 r.p.m. for 10 minutes. The degree of the anti-oxidizing
effect was determined by measuring the absorbance of the supernatant at 532 nm.
The ratio of the value obtained by subtracting the absorbance of the blank
without ADP, NADPH nor FeSO.sub.4.7H.sub.2 O from that of the control with ADP,
NADPH and FeSO.sub.4.7H.sub.2 O to the value of the absorbance of the control
was calculated and shown by percentage as an antioxidation activity.
The results are shown in FIG. 2(a).
2 A liver was taken out from a rat whose head had been cut off, homogenized in a
150 mM KCl-50 mM Tris HCl buffer (pH 7.4) and centrifuged at 9,000 G for 3
minutes and then at 105,000 G for one hour to obtain a microsome suspension. The
suspension was diluted as described in 1 to form a suspension containing 1 mg of
protein per 1 ml of buffer as measured by the Lowry's method.
The suspension was placed in a test tube, followed by the addition of a proper
amount of an antioxidant of the present invention and such an amount of
adriamycin as to give a final concentration of 100 .mu.M. Then, 1.9 mM NADP, 20
mM glucose-6-phosphoric acid, 1.1 I.U./ml glucose-6-phosphoric acid
dehydrogenase and 8.6 mM magnesium chloride were added to the test tube each in
the form of aqueous solution to give a total amount of 1.75 ml. As described in
1, the solution was treated in a thermostatic chamber and the degree of the
antioxidizing effect was determined by measuring the absorbance of the
supernatant at 532 nm.
The blank and control were prepared as in 1.
The results are shown in FIG. 2(b).
* * * * *
|
I promise to answer your message -- click here to send me a personal message
|
SUBSCRIBE: The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren. You can view more than 50 back issues of this publication by clicking here. The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter. It is automatically published on the Tuesday night just before the first Wednesday of every month. You can subscribe to this free monthly electronic letter by entering your eMail address and name below. You will then automatically receive a request for confirmation, sent to whatever address you have entered. If you do NOT receive this confirmation request, then you will not be subscribed. There may have been an error with your address and you should resubmit. The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription. When you receive this confirmation request you must reply to it, or your subscription will not become active. No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.
REMOVAL: You can remove yourself from the subscription list in several different ways. Click here to read about this entire newsletter system. Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list. If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed. Thus, no one else can unsubscribe you, from some other computer, without your knowledge. But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.
Personal Message: When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions. Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US. You can select particular information you would like to receive, along with the free cassette tape and catalog.
You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504. Within the US and Canada, use the toll free number: (800) 523-4521, the local number: (818) 558-1799, the FAX: (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites. Vibrant Life normally ships the same day we get an order. There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life. Check out our companion site, at: http://www.oralchelation.net where Karl's 2000 page book is published. Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION. His personal philosophical articles are at PHILOSOPHY.
Copyright © May 20, 2008 6:25 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED. Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions: One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site. This permission does not extend to materials on this site which are copyrighted by others.